Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

April 01, 2007 (Vol. 27, No. 7)

Keeping an Eye on Rising Biotech Firms

Roth Conference Showcases Potential Winners in the Long-Term Life Science Stock Market

  • Biotechnology, drug discovery, and drug delivery were in the spotlight when Roth Capital Partners hosted its “19th Annual Stock Conference” recently. About 300 companies from diverse industry sectors made presentations during the conference. The average market cap of the presenting companies was approximately $360 million in keeping with ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.